SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Feb 3, 2014
Document Date
Feb 3, 2014
Form Description
Amended Registration statement for face-amount certificate companies
Filing Group
Registration Statements
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.